Handchirurgie,Unfallchirurgie & Physiotherapie

Studie bezüglich Kollagenase und Dupuytren

 




Eine weitere 2019 erstellte Studie aus Österreich unter Führung der Universitätsklinik Innsbruck (Univ. Prof. Dr. Rohit Arora, Peter Angermann, Paul Aspalter und andere...):


Im Internet frei abrufbar:


"Prospective observation of Clostridium histolyticum collagenase for treatment of Dupuytren`s disease in 788 patients: the Austrian register", in Actives of Orthopaedics and Trauma Surgery(2019) 139: 1315-1321. Handsurgery, Springer Verlag.

...."with similar findings!"


Conclusion:

Collagenase treatment:

....earlier return-to-function

....less disability and medically related absentism from work

....less invasive procedure

....less pain

....less scarring

...similar recurrence rate to fasciectomy!

...96 % satisfaction with treatment after 1 year!


Weitere Informationen: paul.aspalter@gmx.at

Ordination: ++43 677/61859021




 
 
 
Mail
Call
Map
About